BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 23649000)

  • 1. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortening of the electromechanical window in the ketamine/xylazine-anesthetized guinea pig model to assess pro-arrhythmic risk in early drug development.
    Morissette P; Regan C; Fitzgerald K; Gerenser P; Travis J; Wang S; Fanelli P; Sannajust F
    J Pharmacol Toxicol Methods; 2016; 81():171-82. PubMed ID: 27377419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay.
    Morissette P; Polak S; Chain A; Zhai J; Imredy JP; Wildey MJ; Travis J; Fitzgerald K; Fanelli P; Passini E; Rodriguez B; Sannajust F; Regan C
    Toxicol Appl Pharmacol; 2020 Mar; 390():114883. PubMed ID: 31981640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
    Cheng HC; Incardona J
    J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.
    Chaves AA; Keller WJ; O'Sullivan S; Williams MA; Fitzgerald LE; McPherson HE; Goykhman D; Ward PD; Hoe CM; Mixson L; Briscoe RJ
    J Pharmacol Toxicol Methods; 2006; 54(2):150-8. PubMed ID: 16679034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
    Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval.
    Cheng HC; Incardona J; McCullough B
    J Pharmacol Toxicol Methods; 2006; 54(3):278-87. PubMed ID: 16507347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
    De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
    Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
    Beattie KA; Luscombe C; Williams G; Munoz-Muriedas J; Gavaghan DJ; Cui Y; Mirams GR
    J Pharmacol Toxicol Methods; 2013; 68(1):88-96. PubMed ID: 23624022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
    Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
    J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
    Bass AS; Hanson LA; Jackson TA
    J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
    Hey JA; del Prado M; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of gefitinib-induced QT prolongation.
    Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
    Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
    Yue Y; Castrichini M; Srivastava U; Fabris F; Shah K; Li Z; Qu Y; El-Sherif N; Zhou Z; January C; Hussain MM; Jiang XC; Sobie EA; Wahren-Herlenius M; Chahine M; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
    Circulation; 2015 Jul; 132(4):230-40. PubMed ID: 25995318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates.
    Guo L; Dong Z; Guthrie H
    J Pharmacol Toxicol Methods; 2009; 60(2):130-51. PubMed ID: 19616638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs.
    Shiotani M; Harada T; Abe J; Hamada Y; Horii I
    J Pharmacol Toxicol Methods; 2007; 55(1):27-34. PubMed ID: 16831559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.
    Guns PJ; Johnson DM; Weltens E; Lissens J
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):125-34. PubMed ID: 22516473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.